Effect of honey bee venom on lewis rats with experimental allergic encephalomyelitis, a model for multiple sclerosis

Akbar Karimi1, Farhad Ahmadi, Kazem Parivar

  • 1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Insights

Bee venom (BV) treatment effectively reduced multiple sclerosis (MS) symptoms in an animal model. This neuroprotective effect was observed through decreased inflammation, demyelination, and key inflammatory markers in the central nervous system.

Area of Science:

  • Neuroscience
  • Immunology
  • Toxicology

Background:

  • Multiple sclerosis (MS) is a CNS autoimmune disease causing neurodegeneration.
  • Experimental allergic encephalomyelitis (EAE) serves as a key animal model for MS research.
  • Honey bee venom (BV) possesses known anti-inflammatory properties.

Purpose of the Study:

  • To investigate the therapeutic potential of bee venom (BV) in an EAE model of MS.
  • To evaluate BV's effects on clinical symptoms, neuropathology, and inflammatory markers in EAE rats.

Main Methods:

  • EAE was induced in Lewis rats using guinea pig spinal cord homogenate (GPSCH) and Complete Freund's Adjuvant (CFA).
  • Bee venom (BV) was administered to EAE rats for treatment.
  • Histopathological analysis (H&E, Luxol fast blue) assessed inflammation and demyelination.
  • ELISA and HPLC measured serum levels of TNF-α and nitrates, respectively.

Main Results:

  • BV treatment significantly decreased clinical EAE scores and pathological damage.
  • Reduced inflammatory cell infiltration and demyelination were observed in the CNS of BV-treated rats.
  • Serum levels of tumor necrosis factor alpha (TNF-α) and nitrates were significantly lowered by BV treatment.

Conclusions:

  • Bee venom (BV) demonstrates significant therapeutic potential in mitigating the effects of experimental allergic encephalomyelitis (EAE).
  • BV's anti-inflammatory and neuroprotective actions suggest its utility in managing MS-like conditions.

Related Concept Videos